MIR6761

Across TCGA pan-cancer cohorts, MIR6761 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6761’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MIR6761 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR6761 is over-expressed in tumor, although a few such as LUSC and UCEC show the opposite, repressed pattern.

LUSC, COAD, and UCEC are the cancer types where MIR6761 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6761 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.386	<.001	5	view →
COAD	All	II,III,IV	+0.388	.023	3	view →
UCEC	All	All	−0.252	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR6761–LUSC

Open the LUSC breakdown →